We are live on ! Find out more
CTA

Carillon Tower Advisers Portfolio holdings

AUM $16.4B
1-Year Est. Return 64.75%
This Fund
S&P 500
This Quarter Est. Return
+36.45%
1 Year Est. Return
+64.75%
3 Year Est. Return
+147.06%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$13B
AUM Growth
+$2.78B
Cap. Flow
-$835M
Cap. Flow %
-6.43%
Top 10 Hldgs %
11.13%
Holding
487
New
48
Increased
80
Reduced
272
Closed
26

Top Buys

Rank Stock Value
1
RMD icon
ResMed
RMD
+$52.9M
2
WST icon
West Pharmaceutical
WST
+$39.7M
3
AMED
Amedisys
AMED
+$36.8M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$34M
5
SPOT icon
Spotify
SPOT
+$34M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$100M
2
CNC icon
Centene
CNC
+$90.3M
3
SBAC icon
SBA Communications
SBAC
+$56.2M
4
HXL icon
Hexcel
HXL
+$45.6M
5
EXAS
Exact Sciences
EXAS
+$44.1M

Sector Composition

Rank Sector Weight
1 Technology 25.62%
2 Healthcare 22.32%
3 Industrials 14.01%
4 Consumer Discretionary 12.64%
5 Financials 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRPT icon
76
Sarepta Therapeutics
SRPT
$1.57B
$54.5M 0.42%
339,743
– –
IQV icon
77
IQVIA
IQV
$38.7B
$54.5M 0.42%
383,817
– –
CPAY icon
78
Corpay
CPAY
$25B
$53.9M 0.42%
214,407
-29,825
-12% -$7.08M
WING icon
79
Wingstop
WING
$3.53B
$53.5M 0.41%
384,999
-11,327
-3% -$1.32M
PTON icon
80
Peloton Interactive
PTON
$2.77B
$53.3M 0.41%
922,670
-34,250
-4% -$1.42M
NOW icon
81
ServiceNow
NOW
$115B
$53M 0.41%
654,030
-252,575
-28% -$17.8M
WAB icon
82
Wabtec
WAB
$49.1B
$52.2M 0.4%
905,909
– –
SPOT icon
83
Spotify
SPOT
$103B
$51.2M 0.39%
+198,201
New +$34M
EVBG
84
DELISTED
Everbridge, Inc. Common Stock
EVBG
$49.1M 0.38%
355,106
-9,563
-3% -$1.24M
BALL icon
85
Ball Corp
BALL
$17.3B
$48.6M 0.38%
700,106
– –
ALB icon
86
Albemarle
ALB
$13.9B
$48.5M 0.37%
627,903
– –
LPLA icon
87
LPL Financial
LPLA
$28.3B
$48.3M 0.37%
615,977
+144,111
+31% +$9.63M
MTN icon
88
Vail Resorts
MTN
$5.32B
$48M 0.37%
263,455
-18,548
-7% -$3.24M
GTLS
89
DELISTED
Chart Industries
GTLS
$47.8M 0.37%
986,223
-206,555
-17% -$7.57M
NEO icon
90
NeoGenomics
NEO
$1.96B
$47.4M 0.37%
1,528,768
-273,883
-15% -$7.59M
TTWO icon
91
Take-Two Interactive
TTWO
$45.4B
$46.7M 0.36%
334,711
– –
AAPL icon
92
Apple
AAPL
$4.54T
$46.4M 0.36%
509,064
-36,000
-7% -$2.79M
WST icon
93
West Pharmaceutical
WST
$24B
$45.9M 0.35%
+202,153
New +$39.7M
LHCG
94
DELISTED
LHC Group LLC
LHCG
$45.8M 0.35%
262,758
+138,459
+111% +$20.3M
TNDM icon
95
Tandem Diabetes Care
TNDM
$1.34B
$45.4M 0.35%
458,915
-303,632
-40% -$24.2M
CTVA icon
96
Corteva
CTVA
$52.6B
$44.7M 0.34%
1,668,187
– –
STZ icon
97
Constellation Brands
STZ
$22.2B
$44.4M 0.34%
253,968
-24,079
-9% -$4.01M
WWD icon
98
Woodward
WWD
$21.5B
$43.6M 0.34%
561,600
-108,661
-16% -$7.1M
TREX icon
99
Trex
TREX
$4.51B
$43.4M 0.33%
667,918
-401,816
-38% -$21.4M
CHGG icon
100
Chegg
CHGG
$110M
$43.1M 0.33%
641,154
-90,467
-12% -$4.83M
2 3
4
5 6

Similar funds

GAM
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SWM
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
HCMNY
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
BII
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return
HCM
Horan Capital Management Hunt Valley, Maryland $794M AUM 30.86% 1-Year Est. Return
DBC
Deep Basin Capital Stamford, Connecticut $739M AUM 4.75% 1-Year Est. Return

Carillon Tower Advisers's Q2 2020 Portfolio in Review

As of Q2 2020, Carillon Tower Advisers held 487 positions worth $13B, up 27% from $10.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Carillon Tower Advisers withdrew a net $835M in Q2 2020, closing 26 positions and reducing 272 holdings. Its most notable exit was Exact Sciences, an estimated $44.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Carillon Tower Advisers opened a new position in ResMed worth $62M.

  • Carillon Tower Advisers's largest Q2 2020 buy was ResMed: 323,155 shares worth $62M.
  • Carillon Tower Advisers added most to Amedisys in Q2 2020, an estimated $36.8M increase.
  • Carillon Tower Advisers's biggest Q2 2020 reduction was Global Payments, cutting an estimated $100M.
  • Carillon Tower Advisers fully exited Exact Sciences in Q2 2020, selling an estimated $44.1M.
  • Carillon Tower Advisers's ten largest holdings make up 11% of its $13B portfolio in Q2 2020.
  • Carillon Tower Advisers opened 48 new positions and closed 26 in Q2 2020.
  • Carillon Tower Advisers's portfolio value rose 27% quarter-over-quarter to $13B.

Based on Carillon Tower Advisers's 13F filing for Q2 2020, filed 12 Aug 2020.